Our identifications provide further support for three genes previously implicated by GWAS, whose expression was significantly associated with a possible causal change in PD risk by summary-based Mendelian randomization, including MMRN1, GPNMB, and GAK5. This evidence concerns the gene GPNMB and Parkinson disease.